A citation-based method for searching scientific literature

K Hirabayashi, J Graham. Am J Obstet Gynecol 1970
Times Cited: 95







List of co-cited articles
530 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Pathogenesis of ascites in peritoneal carcinomatosis.
P HOLM-NIELSEN. Acta Pathol Microbiol Scand 1953
68
35


Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.
D R Senger, S J Galli, A M Dvorak, C A Perruzzi, V S Harvey, H F Dvorak. Science 1983
17

Mechanisms of malignant ascites production.
R N Garrison, R H Galloway, L S Heuser. J Surg Res 1987
59
25

Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation.
J A Nagy, E M Masse, K T Herzberg, M S Meyers, K T Yeo, T K Yeo, T M Sioussat, H F Dvorak. Cancer Res 1995
255
14




Malignant ascites. Clinical and experimental observations.
R N Garrison, L D Kaelin, R H Galloway, L S Heuser. Ann Surg 1986
151
12

Pathogenesis of ascites in mice with peritoneal carcinomatosis.
J Fastaia, A E Dumont. J Natl Cancer Inst 1976
37
27



Markedly elevated levels of vascular endothelial growth factor in malignant ascites.
B K Zebrowski, W Liu, K Ramirez, Y Akagi, G B Mills, L M Ellis. Ann Surg Oncol 1999
186
8

Studies on a transplantable teratoma of the mouse.
E FEKETE, M A FERRIGNO. Cancer Res 1952
90
7


Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining.
J A Nagy, E S Morgan, K T Herzberg, E J Manseau, A M Dvorak, H F Dvorak. Cancer Res 1995
148
7

Ascites, pathophysiology and control measures.
S Lifshitz. Int J Radiat Oncol Biol Phys 1982
13
53

Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
K T Yeo, H H Wang, J A Nagy, T M Sioussat, S R Ledbetter, A J Hoogewerf, Y Zhou, E M Masse, D R Senger, H F Dvorak. Cancer Res 1993
182
7

Analysis of Twenty-three plasma proteins in ascites. The depletion of fibrinogen and plasminogen.
J M Henderson, S F Stein, M Kutner, M B Wiles, J D Ansley, D Rudman. Ann Surg 1980
49
14

Peritoneo-venous shunting for ascites.
H H Leveen, G Christoudias, M Ip, R Luft, G Falk, S Grosberg. Ann Surg 1974
390
7

Peritoneovenous shunting in the management of malignant ascites.
A K Straus, D L Roseman, T M Shapiro. Arch Surg 1979
66
10

The biochemical diagnosis of ovarian cancer.
L McGowan, R H Davis, B Bunnag. Am J Obstet Gynecol 1973
41
14

Investigation of the permeability factor in ascites and edema using albumin tagged with I 131.
J A SHOENBERGER, G KROLL, A SAKAMOTO, R M KARK. Gastroenterology 1952
45
13



Secretion of vascular endothelial growth factor in ovarian cancer.
A D Santin, P L Hermonat, A Ravaggi, M J Cannon, S Pecorelli, G P Parham. Eur J Gynaecol Oncol 1999
84
7

Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
A Kraft, K Weindel, A Ochs, C Marth, J Zmija, P Schumacher, C Unger, D Marmé, G Gastl. Cancer 1999
288
6


The removal of free red blood cells from the peritoneal cavity of animals.
F C COURTICE, J HARDING, A W STEINBECK. Aust J Exp Biol Med Sci 1953
86
6




Pepstatin, an inhibitor of leukokinin formation and ascitic fluid accumulation.
L M Greenbaum, P Grebow, M Johnston, A Prakash, G Semente. Cancer Res 1975
42
11

Human malignant ascites and histamine-induced protein leakage from the normal microcirculation.
M J White, F N Miller, L S Heuser, C G Pietsch. Microvasc Res 1988
23
21

Epidermal growth factor and transforming growth factor alpha induce ascitic fluid in mice.
E Ohmura, T Tsushima, Y Kamiya, M Okada, N Onoda, K Shizume, H Demura. Cancer Res 1990
24
20

Symptomatology of ovarian cancer.
F Flam, N Einhorn, K Sjövall. Eur J Obstet Gynecol Reprod Biol 1988
74
6


Stage IV ovarian cancer: impact of surgical debulking.
J P Curtin, R Malik, E S Venkatraman, R R Barakat, W J Hoskins. Gynecol Oncol 1997
150
5

Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study.
J I Akahira, H Yoshikawa, Y Shimizu, R Tsunematsu, T Hirakawa, H Kuramoto, K Shiromizu, K Kuzuya, T Kamura, Y Kikuchi,[...]. Gynecol Oncol 2001
92
5


Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation.
Dorina Belotti, Paola Paganoni, Luigi Manenti, Angela Garofalo, Sergio Marchini, Giulia Taraboletti, Raffaella Giavazzi. Cancer Res 2003
246
5

Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model.
Annette T Byrne, Leorah Ross, Joceyln Holash, Mikiye Nakanishi, Limin Hu, Judith I Hofmann, George D Yancopoulos, Robert B Jaffe. Clin Cancer Res 2003
235
5


Fatal pulmonary tumor embolization following peritoneovenous shunting for malignant ascites.
R R Smith, S S Sternberg, M A Paglia, R B Golbey. J Surg Oncol 1981
35
14

Peritoneoscopy: a valuable staging tool in ovarian carcinoma.
S H Rosenoff, R C Young, T Anderson, C Bagley, B Chabner, P S Schein, S Hubbard, V T DeVita. Ann Intern Med 1975
76
6

Absorption of serum from the peritoneal cavity.
H E RAYBUCK, L ALLEN, W S HARMS. Am J Physiol 1960
33
15

Intracavitary bleomycin in the management of malignant effusions.
W Paladine, T J Cunningham, R Sponzo, M Donavan, K Olson, J Horton. Cancer 1976
164
5


Angiogenic protein expression in advanced epithelial ovarian cancer.
D P Barton, A Cai, K Wendt, M Young, A Gamero, S De Cesare. Clin Cancer Res 1997
87
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.